Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Risk factors for reporting adverse events and for study withdrawal in a population-based trial of vitamin D supplementation.

Malihi Z, Wu Z, Lawes C, Sluyter J, Waayer D, Toop L, Khaw KT, Camargo CA Jr, Scragg R.

J Steroid Biochem Mol Biol. 2020 Mar;197:105546. doi: 10.1016/j.jsbmb.2019.105546. Epub 2019 Nov 18.

PMID:
31751782
2.

Effect of monthly high-dose vitamin D supplementation on acute respiratory infections in older adults: A randomized controlled trial.

Camargo CA, Sluyter J, Stewart AW, Khaw KT, Lawes CMM, Toop L, Waayer D, Scragg R.

Clin Infect Dis. 2019 Aug 17. pii: ciz801. doi: 10.1093/cid/ciz801. [Epub ahead of print]

PMID:
31420647
3.

Response to "Elephants in the room" editorial, 1 February 2019.

Townsend P, Toop L, Aish H, Jordan L, Cullen F.

N Z Med J. 2019 May 17;132(1495):86-87. No abstract available.

PMID:
31095551
4.

Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial.

Malihi Z, Lawes CMM, Wu Z, Huang Y, Waayer D, Toop L, Khaw KT, Camargo CA, Scragg R.

Am J Clin Nutr. 2019 Jun 1;109(6):1578-1587. doi: 10.1093/ajcn/nqy378.

PMID:
31005969
5.

Association between serum 25-hydroxyvitamin D levels and self-reported chronic pain in older adults: A cross-sectional analysis from the ViDA study.

Wu Z, Camargo CA Jr, Sluyter JD, Khaw KT, Malihi Z, Waayer D, Toop L, Lawes CMM, Scragg R.

J Steroid Biochem Mol Biol. 2019 Apr;188:17-22. doi: 10.1016/j.jsbmb.2018.11.018. Epub 2018 Nov 30.

PMID:
30508645
6.

Cross-sectional associations of vitamin D status with asthma prevalence, exacerbations, and control in New Zealand adults.

Win SS, Camargo CA Jr, Khaw KT, Lawes CMM, Sluyter J, Waayer D, Toop L, Scragg R.

J Steroid Biochem Mol Biol. 2019 Apr;188:1-7. doi: 10.1016/j.jsbmb.2018.11.016. Epub 2018 Nov 30.

PMID:
30508643
7.

Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial.

Malihi Z, Lawes CMM, Wu Z, Huang Y, Waayer D, Toop L, Khaw KT, Camargo CA Jr, Scragg R.

Clin Nutr. 2019 Aug;38(4):1581-1587. doi: 10.1016/j.clnu.2018.07.034. Epub 2018 Aug 4.

PMID:
30146166
8.

Monthly High-Dose Vitamin D Supplementation and Cancer Risk: A Post Hoc Analysis of the Vitamin D Assessment Randomized Clinical Trial.

Scragg R, Khaw KT, Toop L, Sluyter J, Lawes CMM, Waayer D, Giovannucci E, Camargo CA Jr.

JAMA Oncol. 2018 Nov 1;4(11):e182178. doi: 10.1001/jamaoncol.2018.2178. Epub 2018 Nov 8.

9.

Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study.

Wu Z, Camargo CA Jr, Khaw KT, Waayer D, Lawes CMM, Toop L, Scragg R.

Atherosclerosis. 2018 Jun;273:59-66. doi: 10.1016/j.atherosclerosis.2018.04.009. Epub 2018 Apr 7.

PMID:
29684661
10.

Monthly vitamin D supplementation, pain, and pattern of analgesic prescription: secondary analysis from the randomized, double-blind, placebo-controlled Vitamin D Assessment study.

Wu Z, Camargo CA Jr, Malihi Z, Bartley J, Waayer D, Lawes CMM, Toop L, Khaw KT, Scragg R.

Pain. 2018 Jun;159(6):1074-1082. doi: 10.1097/j.pain.0000000000001189.

PMID:
29494417
11.

Effect of Monthly, High-Dose, Long-Term Vitamin D on Lung Function: A Randomized Controlled Trial.

Sluyter JD, Camargo CA, Waayer D, Lawes CMM, Toop L, Khaw KT, Scragg R.

Nutrients. 2017 Dec 13;9(12). pii: E1353. doi: 10.3390/nu9121353.

12.

Effect of Monthly, High-Dose, Long-Term Vitamin D Supplementation on Central Blood Pressure Parameters: A Randomized Controlled Trial Substudy.

Sluyter JD, Camargo CA Jr, Stewart AW, Waayer D, Lawes CMM, Toop L, Khaw KT, Thom SAM, Hametner B, Wassertheurer S, Parker KH, Hughes AD, Scragg R.

J Am Heart Assoc. 2017 Oct 24;6(10). pii: e006802. doi: 10.1161/JAHA.117.006802.

13.

Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial.

Khaw KT, Stewart AW, Waayer D, Lawes CMM, Toop L, Camargo CA Jr, Scragg R.

Lancet Diabetes Endocrinol. 2017 Jun;5(6):438-447. doi: 10.1016/S2213-8587(17)30103-1. Epub 2017 Apr 28.

PMID:
28461159
14.

Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.

Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, Murphy J, Khaw KT, Camargo CA Jr.

JAMA Cardiol. 2017 Jun 1;2(6):608-616. doi: 10.1001/jamacardio.2017.0175.

15.

Pilot study of methods for assessing unmet secondary health care need in New Zealand.

Bagshaw P, Bagshaw S, Frampton C, Gauld R, Green T, Harris C, Hornblow A, Hudson B, Raymont A, Richardson A, Shaw C, Toop L.

N Z Med J. 2017 Mar 24;130(1452):23-38.

PMID:
28337038
16.

Steps towards more integrated care in New Zealand: a general practice perspective.

Toop L.

BJGP Open. 2017 Mar 15;1(1):bjgpopen17X100845. doi: 10.3399/bjgpopen17X100845. No abstract available.

17.

Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?

Swinburn B, Vandevijvere S, Woodward A, Hornblow A, Richardson A, Burlingame B, Borman B, Taylor B, Breier B, Arroll B, Drummond B, Grant C, Bullen C, Wall C, Mhurchu CN, Cameron-Smith D, Menkes D, Murdoch D, Mangin D, Lennon D, Sarfati D, Sellman D, Rush E, Sopoaga F, Thomson G, Devlin G, Abel G, White H, Coad J, Hoek J, Connor J, Krebs J, Douwes J, Mann J, McCall J, Broughton J, Potter JD, Toop L, McCowan L, Signal L, Beckert L, Elwood M, Kruger M, Farella M, Baker M, Keall M, Skeaff M, Thomson M, Wilson N, Chandler N, Reid P, Priest P, Brunton P, Crampton P, Davis P, Gendall P, Howden-Chapman P, Taylor R, Edwards R, Beaglehole R, Doughty R, Scragg R, Gauld R, McGee R, Jackson R, Hughes R, Mulder R, Bonita R, Kruger R, Casswell S, Derrett S, Ameratunga S, Denny S, Hales S, Pullon S, Wells S, Cundy T, Blakely T.

N Z Med J. 2017 Feb 17;130(1450):94-101.

PMID:
28207729
18.

Restoring Study 329: Paroxetine neither effective nor safe for adolescents.

Mulder R, Rucklidge JJ, Toop L.

Aust N Z J Psychiatry. 2016 Sep;50(9):922-3. doi: 10.1177/0004867416657412. Epub 2016 Jul 7. No abstract available.

PMID:
27389067
19.

Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial.

Hudson B, Williman JA, Stamp LK, Alchin JS, Hooper GJ, Mangin D, Thompson BF, Toop L.

Trials. 2015 Oct 9;16:448. doi: 10.1186/s13063-015-0961-1.

20.

The art and science of marketing medications.

Toop L, Mangin D.

N Z Med J. 2015 Sep 4;128(1421):11-2. No abstract available.

PMID:
26370750
21.

The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures.

Scragg R, Waayer D, Stewart AW, Lawes CMM, Toop L, Murphy J, Khaw KT, Camargo CA Jr.

J Steroid Biochem Mol Biol. 2016 Nov;164:318-325. doi: 10.1016/j.jsbmb.2015.09.010. Epub 2015 Sep 10.

PMID:
26365555
22.

Patient co-payment for general practice services: slippery slope or a survival imperative for the NHS?

Toop L, Jackson C.

Br J Gen Pract. 2015 Jun;65(635):276-7. doi: 10.3399/bjgp15X685105. No abstract available.

23.

Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.

Hudson B, Toop L, Mangin D, Brunton C, Jennings L, Fletcher L.

Br J Gen Pract. 2013 Jun;63(611):e416-22. doi: 10.3399/bjgp13X668212.

24.

Crying and spilling--time to stop the overmedicalisation of normal infant behaviour.

Hudson B, Alderton A, Doocey C, Nicholson D, Toop L, Day AS.

N Z Med J. 2012 Dec 14;125(1367):119-26. Review.

PMID:
23321888
25.

Direct-to-consumer genetic testing: letting the genie out of the bottle?

Mangin D, Hudson B, Toop L.

N Z Med J. 2012 Oct 26;125(1364):7-10. No abstract available.

PMID:
23242392
26.

Chlamydia trachomatis testing sensitivity in midstream compared with first-void urine specimens.

Mangin D, Murdoch D, Wells JE, Coughlan E, Bagshaw S, Corwin P, Chambers S, Toop L.

Ann Fam Med. 2012 Jan-Feb;10(1):50-3. doi: 10.1370/afm.1323.

27.

Risk communication methods in hip fracture prevention: a randomised trial in primary care.

Hudson B, Toop L, Mangin D, Pearson J.

Br J Gen Pract. 2011 Aug;61(589):e469-76. doi: 10.3399/bjgp11X588439.

28.

The QOF, NICE, and depression: a clumsy mechanism that undermines clinical judgment.

Toop L.

Br J Gen Pract. 2011 Jul;61(588):432-3. doi: 10.3399/bjgp11X582994. No abstract available.

29.

The future of national health systems.

Heath I, Mangin D, Toop L, Brodersen J.

Br J Gen Pract. 2011 May;61(586):319-20. doi: 10.3399/bjgp11X572292. No abstract available.

30.

1998 vision for year 2003 for members of Pegasus Medical Group.

Toop L.

J Prim Health Care. 2011 Mar 1;3(1):79-81. No abstract available.

PMID:
21359270
31.

A dipstick clinical prediction rule modestly improved diagnostic precision in women with suspected urinary tract infection.

Toop L, Mangin DR.

Evid Based Med. 2009 Oct;14(5):155. doi: 10.1136/ebm.14.5.155. No abstract available.

PMID:
19794030
32.

A polypill is the solution to the pharmacological management of cardiovascular risk: no.

Toop L.

J Prim Health Care. 2009 Sep;1(3):234-6. No abstract available.

PMID:
21534329
33.

Provision of information on regulatory authorities' websites.

Vitry A, Lexchin J, Sasich L, Dupin-Spriet T, Reed T, Bertele V, Garattini S, Toop L, Hurley E.

Intern Med J. 2008 Jul;38(7):559-67. doi: 10.1111/j.1445-5994.2007.01588.x. Epub 2008 Mar 11.

PMID:
18336542
34.

Quality and outcomes framework. Evidence of net benefit is lacking.

Toop LJ, Mangin D.

BMJ. 2007 Dec 8;335(7631):1170. No abstract available.

35.

Industry funded patient information and the slippery slope to New Zealand.

Toop L, Mangin D.

BMJ. 2007 Oct 6;335(7622):694-5. No abstract available.

36.

The Quality and Outcomes Framework: what have you done to yourselves?

Mangin D, Toop L.

Br J Gen Pract. 2007 Jun;57(539):435-7. No abstract available.

37.

Urinary tract infection in primary care.

Mangin D, Toop L.

BMJ. 2007 Mar 24;334(7594):597-8. No abstract available.

38.

Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?

Mangin D, Toop L, Chambers S, Ikram R, Harris B.

N Z Med J. 2005 Nov 11;118(1225):U1726.

PMID:
16286940
39.

Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial.

Richards DA, Toop LJ, Epton MJ, McGeoch GR, Town GI, Wynn-Thomas SM, Dawson RD, Hlavac MC, Werno AM, Abernethy PD.

Med J Aust. 2005 Sep 5;183(5):235-8.

PMID:
16138795
40.

Response to Maubach and Hoek's paper on GP attitudes to DTCA.

Toop L, Richards D, Dowell T.

N Z Med J. 2005 Jun 24;118(1217):U1543. No abstract available.

PMID:
15980914
41.
42.

Direct to consumer advertising.

Mansfield PR, Mintzes B, Richards D, Toop L.

BMJ. 2005 Jan 1;330(7481):5-6. No abstract available.

43.

Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.

Corwin P, Toop L, McGeoch G, Than M, Wynn-Thomas S, Wells JE, Dawson R, Abernethy P, Pithie A, Chambers S, Fletcher L, Richards D.

BMJ. 2005 Jan 15;330(7483):129. Epub 2004 Dec 16.

44.

Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.

Toop L, Richards D.

N Z Med J. 2004 Jun 4;117(1195):U905. No abstract available.

PMID:
15282619
45.

The use of inhaled and related respiratory medications in Christchurch rest homes.

Botting C, Sutherland M, Wells E, Town I, Sainsbury R, Toop L.

N Z Med J. 2003 Dec 12;116(1187):U709.

PMID:
14752537
46.

Last time around for DTCA.

Toop L.

N Z Med J. 2003 Nov 21;116(1186):U693; author reply U693. No abstract available.

PMID:
14657972
47.

New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?

Toop L, Richards D, Saunders B.

N Z Med J. 2003 Aug 22;116(1180):U556; discussion U556. No abstract available.

PMID:
14581976
49.

Improving the effectiveness of smoking cessation in primary care: lessons learned.

Richards D, Toop L, Brockway K, Graham S, McSweeney B, MacLean D, Sutherland M, Parsons A.

N Z Med J. 2003 May 2;116(1173):U417.

PMID:
12740611
50.

Do clinical practice education groups result in sustained change in GP prescribing?

Richards D, Toop L, Graham P.

Fam Pract. 2003 Apr;20(2):199-206.

PMID:
12651796

Supplemental Content

Support Center